Moxetumomab pasudotox and Promacot Injection, Intravenous
Determining the interaction of Moxetumomab pasudotox and Promacot Injection, Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: promethazine
Brand name: Phenergan, Phenadoz, Promethegan
Synonyms: Promethazine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Promacta
- Moxetumomab pasudotox-Promacta (Eltrombopag Powder for Suspension)
- Moxetumomab pasudotox-Promacta (Eltrombopag Tablets)
- Moxetumomab pasudotox-Promethazine
- Moxetumomab pasudotox-Promethazine and Phenylephrine
- Moxetumomab pasudotox-Promethazine Hydrochloride
- Promacot Injection, Intravenous-Moxetumomab Pasudotox-tdfk
- Promacot Injection, Intravenous-Moxetumomab pasudotox-tdfk Intravenous
- Promacot Injection, Intravenous-Moxifloxacin
- Promacot Injection, Intravenous-Moxifloxacin (Systemic)
- Promacot Injection, Intravenous-Moxifloxacin Hydrochloride
- Promacot Injection, Intravenous-Moxifloxacin Injection